1. Animal Pharm 2001 Report. Animal Pharm, 69-77 Paul Street, London.
2. Vetnosis Limited 2006 Report. Vetnosis Limited (Former Animal Health business of Wood Mackenzie), 74-77 Queen Street, Edinburgh.
3. Hardee GE, Baggott JD, eds. Development and Formulation of Dosage Forms. 2nd ed. New York: Marcel Dekker, 1998.
4. Chien YW. Controlled administration of estrus-synchronizing agents in livestock. In: Chien YW, ed. Novel Drug Delivery Systems; Fundamentals Developmental Concepts Biomedical Assessments. New York: Marcel Dekker, 1982:413-463.
5. Pope DG, Baggot JD. Special considerations in veterinary formulation design. Int J Pharm 1983; 14:123-132.
6. Chien YW. Implantable therapeutic systems. In: Robinson JR, Lee VHL, eds. Controlled drug delivery. New York: Marcel Dekker, 1987:481-522.
7. Baggott JD. Veterinary drug formulations for animal health care: an overview. J Control Release 1988; 8:5-13.
8. Carter DH, Luttinger M, Gardner DC. Controlled release parenteral systems for veterinary applications. J Control Release 1988; 8:15-22.
9. Koestler RC, Janes G, Miller JA. Pesticide delivery. In: Kydonieus A, ed. Treatise on Controlled Drug Delivery. New York: Marcel Dekker, 1992:491-543.
10. Arnold RG. Controlled release new animal drugs. J Control Release 1988; 8:85-90.
11. Cardinal JR, Witchey-Lakshmanan LC. Drug delivery in veterinary medicine. In: Kydonieus A, ed. Treatise on Controlled Drug Delivery. New York: Marcel Dekker, 1992:465-489.
12. Baggot JD. Special issue on veterinary drug delivery. J Control Release 1988; 8:3-91.
13. Rathbone MJ, Gurny R, eds. Controlled Release Veterinary Drug Delivery: Biological and Pharmaceutical Considerations. The Netherlands: Elsevier Science BV, 2000.
14. Rathbone MJ (Theme Editor). Veterinary drug delivery. Part I. Special theme issue. Adv Drug Deliv Rev 1997; 28(3):91pp.
15. Rathbone MJ, Cady SM (Theme Editors). Veterinary drug delivery. Part II. Special theme issue. Adv Drug Deliv Rev 1998; 38(2):83pp.
16. Rathbone MJ, Witchey-Lakshmaman L (Theme Editors). Veterinary drug delivery. Part III. Special theme Issue. Adv Drug Deliv Rev 2000; 43(l):92pp.
17. Rathbone MJ, Witchey-Lakshmaman L (Theme Editors). Veterinary drug delivery. Part IV. Special theme issue. Adv Drug Deliv Rev 2001; 50(3):147pp.
18. Rathbone MJ (Theme Editor). Veterinary drug delivery. Part V. Special theme issue. Adv Drug Deliv Rev 2002; 54(6):97pp.
19. Rathbone MJ, Bowersock T, (Guest Editors). Veterinary drug delivery (special issue). J Control Release 2002; 85(1-3):284pp.
20. Rathbone MJ, Macmillan KL, Inskeep K, et al. Fertility regulation in cattle. J Control Rel 1997; 54:117-148.
21. Rathbone MJ, Macmillan KL, Jöchle W, et al. Controlled release products for the control of the estrous cycle in cattle sheep goats deer pigs and horses. Crit Rev Ther Drug Carrier Syst 1998; 15:285-380.
22. Rathbone MJ, Martinez MN. Linking human and veterinary health: trends directions and initiatives. AAPS PharmSci 2002; 4 (article 32). Available at: http://www.aapsj.org/view.asp? art=ps040432
23. Rathbone MJ, Martinez MN. Modified release drug delivery in veterinary medicine. Drug Discov Today 2002; 7:823-829.
24. Rotehn-Weinhold A, Dahn M, Gurny R. Formulation and technology aspects of controlled drug delivery in animals. Pharm Sei Technol Today 2000; 3:222-231.
25. Matschke C, Isele U, van Hoogevest P, et al. Sustained release injectables formed in situ and their potential use for veterinary products. J Control Release 2002; 85:1-15.
26. Jalava K, Hensel A, Szostak M, et al. Bacterial ghosts as vaccine candidates for veterinary applications. J Control Release 2002; 85:17-25.
27. Cady SM, Steber WD. Controlled delivery of somatotropins. In: Sanders LM, Hendren P, eds. Protein Delivery: Physical Systems. New York: Plenum Press, 1997:289-317.
28. Ferguson TH. Peptide and protein delivery for animal health applications. In: Park K, ed. Controlled Drug Delivery. Washington, DC, U.S.A.: American Chemical Society, 1997:289-308.
29. Robinson JR, Rathbone MJ. Mucosal drug delivery—rectal uterine and vaginal. In: Mathiowitz E, ed. Encyclopedia of Controlled Drug Delivery. New York: John Wiley and Sons, 1999.
30. Rathbone MJ, Witchey-Lakshmanan L, Ciftci KK. Veterinary applications of controlled release drug delivery. In: Mathiowitz E, ed. Encyclopedia of Controlled Drug Delivery. New York: John Wiley and Sons, 1999:1007-1037.
31. Sutton S. Companion animal physiology and dosage from performance. Adv Drug Deliv Rev 2004; 56:1383-1398.
32. Kararli TT. Comparison of the gastrointestinal anatomy physiology and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Dispos 1995; 16:351-380.
33. Dressman JB. Comparison of canine and human gastrointestinal physiology. Pharm Res 1986; 3:123-131.
34. Dressman JB, Yamada K. Animal model for oral drug absorption. In: Welling, PG, Tse FLS, Dighe S, eds. Pharmaceutical Bioequivalence. New York: Marcel Dekker, 1991:235-266.
35. Hernot DC, Dumon HJ, Biourge VC, et al. Evaluation of association between body size and large intestinal transit time in healthy dogs. Am J Vet Res 2006; 67:342-347.
36. Weber MP, Stambouli F, Martin LJ, et al. Influence of age and body size on gastrointestinal transit time of radiopaque markers in healthy dogs. Am J Vet Res 2002; 63:677-682.
37. Weber MP, Martin LJ, Biourge VC, et al. Influence of age and body size on orocecal transit time as assessed by use of the sulfasalazine method in healthy dogs. Am J Vet Res 2003; 64:1105-1109.
38. Hernot DC, Biourge VC, Martin LJ, et al. Relationship between total transit time and faecal quality in adult dogs differing in body size. J Anim Physiol Anim Nutr (Berl) 2005; 89:189-193.
39. Weber MP, Martin LJ, Dumon HJ, et al. Influence of age and body size on intestinal permeability and absorption in healthy dogs. Am J Vet Res 2002; 63:1323-1328.
40. Chiou WL, Jeong HY, Chung SM, et al. Evaluation of using dog as an animal model to study the fraction of oral dose absorbed of 43 drugs in humans. Pharm Res 2000; 17:135-140.
41. Thrombre AG. Oral delivery of medications to companion animals: palatability considerations. Adv Drug Deliv Rev 2004; 56:1399-1413.
42. Compendium of Veterinary Products. 10th ed. Port Huron, Michigan: AJ Bayley (publisher), North American Compendiums, 2007: 501-554.
43. FDA-Center for Veterinary Medicine Guidance Documents. General principles for evaluating the safety of compounds used in food-producing animals Document No. 3. Version July 2006.
44. VICH Guidance Documents. Studies to evaluate the safety of residues of veterinary drugs in human food: general approach to testing. Document GL 33. Version October 2002.
45. Concordet D, Toutain PL. The withdrawal time estimation of veterinary drugs revisited. J Vet Pharmacol Ther 1997; 20:380-386.
46. Reeves PT. Residues of veterinary drugs at injection sites. J Vet Pharmacol Ther 2007; 30:1-17.
47. Robinson JA. Assessing environmental impacts of veterinary products: lessons from VICH. Drug Inf J 2007; 41:169-185.
48. VICH 2000 Environmental Impact Assessment (EIAs) for Veterinary Medicinal Products (VMPs)—Phase I. Topic GL6 (Ecotoxicity Phase I). CVMP/VICH/592/98-Final. Available at: http://wwwemeaeuropaeu/pdfs/vet/vich/059298enpdf.
49. VICH 2004 Environmental Impact Assessment for Veterinary Medicinal Products—Phase n. GL 38 (Ecotoxicity Phase II). CVMP/VICH/790/03-Final. Available at: http://www. emeaeuropaeu/pdfs/vet/vich/079003enpdf.
50. FDA Center for Veterinary Medicine Guidance Documents. Guidance for Industry: Evaluating the Safety of Antimicrobial New Animal Drugs with Regard to Their Microbiological Effects on Bacteria of Human Health Concern. Document No. 152. Version October 2003.
51. Medlicott NJ, Waldron NA, Foster TP. Sustained release veterinary parenteral products. Adv Drug Deliv Rev 2004; 56:1345-1365.
52. Aguiar AJ, Armstrong WA, Desai SJ. Development of Oxytetracycline long-acting injectable. J Control Release 1987; 6:375-385.
53. Cook, DW. Administration devices and techniques. In: Hardee GE, Baggott JD, eds. Development and Formulation of Dosage Forms. 2nd ed. New York: Marcel Dekker, 1998:305-356.
54. Leatherman MW, Stultz TD, Foster TP. Using flow rates to predict syringeability acceptance of veterinary parenteral formulations. Poster presentation at AAPS Annual Meeting, San Diego, CA, 1994.
55. Brown SA. Administration of an injectable antibiotic in the ear of an animal. U.S. patent 6 074 657. 2000.
Was this article helpful?
Stop Your Scalp From Snowing! Finally... A Real Cure for Dandruff! No medication! No weird cures! No messy creams, smelly solutions or strange diets! Are you sick to death of being sold products that could make the problem worse? Are you sick of the shampoos and conditioners that make your head smell like sulphur? If so then try a permanent revolutionary treatment for dandruff!